NITIN CHHABRA: Open Payments
NPI 1811035371 · DALTON, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$673 in 37 payments from 7 companies in 2025. Trend: 2023 $730 · 2024 $1,111 · 2025 $673
Food & beverage: $673
| Company | Payments | Amount |
|---|---|---|
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 25 | $332 |
| Collegium Pharmaceutical, Inc. | 6 | $112 |
| Boston Scientific Corporation | 2 | $96 |
| Stryker Corporation | 1 | $60 |
| VERTEX PHARMACEUTICALS INCORPORATED | 1 | $33 |
| Valinor Pharma, LLC | 1 | $22 |
| Medtronic, Inc. | 1 | $18 |
Products named: RELISTOR, XTAMPZA, MILD DEVICE KIT, Superion Indirect Decompression System, Intracept, JOURNAVX, MOVANTIK, INCEPTIV.
Industry payments across GA — which companies pay providers there.
